These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1812499)

  • 1. Coincidence of schizophrenia and hyperbilirubinemia.
    Müller N; Schiller P; Ackenheil M
    Pharmacopsychiatry; 1991 Nov; 24(6):225-8. PubMed ID: 1812499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome).
    Miyaoka T; Seno H; Itoga M; Iijima M; Inagaki T; Horiguchi J
    J Clin Psychiatry; 2000 Nov; 61(11):868-71. PubMed ID: 11105741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gilbert's syndrome and schizophrenia].
    Molina Ramos R; Villanueva Curto S; Molina Ramos JM
    Actas Esp Psiquiatr; 2006; 34(3):206-8. PubMed ID: 16736395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Schizophrenia and idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome)].
    Miyaoka T
    Seishin Shinkeigaku Zasshi; 2007; 109(4):305-12. PubMed ID: 17561669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.
    Kim YK; Suh IB; Kim H; Han CS; Lim CS; Choi SH; Licinio J
    Mol Psychiatry; 2002; 7(10):1107-14. PubMed ID: 12476326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal fragile site expression in Turkish psychiatric patients.
    Taştemir D; Demirhan O; Sertdemir Y
    Psychiatry Res; 2006 Nov; 144(2-3):197-203. PubMed ID: 17007939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status-dependent neurochemical parameters in schizophrenic and affective diseases].
    Gross G; Huber G; Klosterkötter J; Rao ML; Linz M
    Fortschr Neurol Psychiatr; 1990 Apr; 58(4):154-60. PubMed ID: 1972372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid plasma levels: a marker of impaired central control in psychiatric disorders?
    Brambilla F; Facchinetti F; Petraglia F; Ferrari E; Maggioni M; Genazzani AR
    Adv Biochem Psychopharmacol; 1987; 43():211-20. PubMed ID: 2954437
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between unconjugated bilirubin and schizophrenia.
    Radhakrishnan R; Kanigere M; Menon J; Calvin S; Janish A; Srinivasan K
    Psychiatry Res; 2011 Oct; 189(3):480-2. PubMed ID: 21470692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model.
    Levine J; Sela BA; Osher Y; Belmaker RH
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1181-91. PubMed ID: 16115716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic and clinical features of schizoaffective (schizobipolar) disorder--a 5-year retrospective study. Support for a bipolar spectrum disorder.
    Nardi AE; Nascimento I; Freire RC; de-Melo-Neto VL; Valença AM; Dib M; Soares-Filho GL; Veras AB; Mezzasalma MA; Lopes FL; de Menezes GB; Grivet LO; Versiani M
    J Affect Disord; 2005 Dec; 89(1-3):201-6. PubMed ID: 16202454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients.
    McAdams C; Leonard BE
    Int Clin Psychopharmacol; 1992 Nov; 7(2):81-5. PubMed ID: 1487625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe mental disorders in offspring with 2 psychiatrically ill parents.
    Gottesman II; Laursen TM; Bertelsen A; Mortensen PB
    Arch Gen Psychiatry; 2010 Mar; 67(3):252-7. PubMed ID: 20194825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperbilirubinemia-related behavioral and neuropathological changes in rats: a possible schizophrenia animal model.
    Hayashida M; Miyaoka T; Tsuchie K; Yasuda H; Wake R; Nishida A; Inagaki T; Toga T; Nagami H; Oda T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):581-8. PubMed ID: 19249333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking.
    Yovel G; Sirota P; Mazeh D; Shakhar G; Rosenne E; Ben-Eliyahu S
    Brain Behav Immun; 2000 Sep; 14(3):153-69. PubMed ID: 10970677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.
    Ringen PA; Lagerberg TV; Birkenaes AB; Engn J; Faerden A; Jónsdottir H; Nesvåg R; Friis S; Opjordsmoen S; Larsen F; Melle I; Andreassen OA
    Psychol Med; 2008 Sep; 38(9):1241-9. PubMed ID: 18070373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.